Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.55 |
| ▸ | ITGAV | P06756 | 1/20 | 0.55 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.55 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | CFD | P00746 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 7/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20436312 | 0.88 | ITGB3 (0.60) | ITGB3ITGB1ITGAVITGA5ITGA4 | |
| SCHEMBL20436304 | 0.78 | ITGB3 (0.68) | ITGB3ITGB1ITGAVITGA5ITGA4 | |
| SCHEMBL20436307 | 0.78 | ITGB3 (0.48) | ITGB3ITGB1ITGAVITGA5ITGA4 | |
| SCHEMBL4125057 | 0.74 | ALDH1A1 (0.47) | KMT2AALDH1A1MEN1 | |
| SCHEMBL12348758 | 0.72 | ROCK2 (0.41) | KMT2AALDH1A1CYP2C19MEN1SMN1; SMN2 | |
| SCHEMBL4186674 | 0.70 | KMT2A (0.76) | ITGB3ITGB1ITGAVITGA5ITGA4 | |
| SCHEMBL5105015 | 0.70 | ITGB3 (0.72) | ITGB3ITGB1ITGAVITGA5ITGA4 | |
| SCHEMBL20436313 | 0.70 | ALDH1A1 (0.36) | KMT2AALDH1A1MEN1 | |
| SCHEMBL24200375 | 0.69 | ITGB3 (0.74) | ITGB3ITGB1ITGAVITGA5ITGA4 | |
| SCHEMBL19286172 | 0.68 | ALDH1A1 (0.47) | KMT2AALOX12ALDH1A1CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11327060-B2 | Method for analyzing enantiomer | AJINOMOTO CO., INC. (JP) | 2022-05-10 | — | — | US | disclosed |
| EP-3358346-B1 | ENANTIOMER ANALYSIS METHOD | AJINOMOTO KK (JP) | 2022-01-19 | — | — | EP | disclosed |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | AJINOMOTO CO., INC. (JP) | 2018-08-02 | — | — | US | disclosed |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | AJINOMOTO CO., INC. (JP) | 2018-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11327060-B2 | Method for analyzing enantiomer | DCX, INF2, SRD5A2 | ITGB3 4498/4885ITGB1 4615/4885ITGAV 4755/4885 |
| US-20180217113-A1 | METHOD FOR ANALYZING ENANTIOMER | DCX, INF2, SRD5A2 | ITGB3 4498/4885ITGB1 4615/4885ITGAV 4755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.